- Moneycontrol /
- Market /
- Pharmaceuticals /
- PROFIT LOSS
BSE Live
Aug 07, 10:24Prev. Close
35.15
Open Price
35.85
Bid Price (Qty.)
35.85 (882853)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 83.65 | 34.80 | 124.19 | 128.03 | 146.24 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Revenue From Operations [Net] | 83.65 | 34.80 | 124.19 | 128.03 | 146.22 | |
| Total Operating Revenues | 83.65 | 34.80 | 124.19 | 128.03 | 146.22 | |
| Other Income | 4.22 | 1.39 | 1.18 | 1.39 | 0.73 | |
| Total Revenue | 87.87 | 36.19 | 125.36 | 129.42 | 146.95 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 84.28 | 26.97 | 70.72 | 112.93 | 114.44 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 12.76 | 14.95 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -13.55 | 0.00 | 19.14 | -6.56 | -3.41 | |
| Employee Benefit Expenses | 9.78 | 10.31 | 10.21 | 10.03 | 9.61 | |
| Finance Costs | 2.00 | 0.73 | 3.69 | 2.41 | 1.08 | |
| Depreciation And Amortisation Expenses | 0.28 | 0.41 | 0.58 | 0.65 | 0.91 | |
| Other Expenses | 12.46 | 5.73 | 11.80 | 6.08 | 7.27 | |
| Total Expenses | 95.24 | 44.15 | 116.14 | 138.29 | 144.85 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -7.37 | -7.96 | 9.22 | -8.87 | 2.10 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -7.37 | -7.96 | 9.22 | -8.87 | 2.10 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 1.80 | 0.00 | 0.12 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 1.66 | 0.00 | 0.00 | |
| Deferred Tax | -1.58 | -3.70 | 2.57 | -2.75 | 0.43 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -1.58 | -3.70 | 2.71 | -2.75 | 0.55 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -5.79 | -4.26 | 6.51 | -6.12 | 1.55 | |
| Profit/Loss From Continuing Operations | -5.79 | -4.26 | 6.51 | -6.21 | 1.55 | |
| Profit/Loss For The Period | -5.79 | -4.26 | 6.51 | -6.21 | 1.55 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -1.57 | -0.99 | 1.54 | -1.44 | 0.36 | |
| Diluted EPS (Rs.) | -1.57 | -0.99 | 1.54 | -1.44 | 0.36 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 112.83 | 114.34 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
12.04.2019
Bharat Immuno Standalone March 2019 Net Sales at Rs 70.61 crore, up 225.66% Y-o-Y
31.01.2019
Bharat Immuno Standalone December 2018 Net Sales at Rs 8.28 crore, up 85.45% Y-o-Y
